UK health authorities are scrutinizing a growing number of deaths potentially linked to popular weight-loss drugs, with official figures indicating 216 fatalities suspected to be side effects. While a direct causal link is difficult to establish, these cases have prompted warnings for individuals using such medications.
One case that has raised particular concern involves Caroline Savage, a 73-year-old grandmother who died in October 2024 after experiencing severe stomach pain. Savage had been taking a weight-loss drug, identified as Mounjaro, which contains the active ingredient tirzepatide. She developed faecal peritonitis, a condition where fecal matter leaks from the intestines, which has not been previously associated with these medications. Savage had been using the drug since 2024 to manage weight and lipedema, a condition causing fat accumulation in the limbs.
Another reported death involved Josephine Nasr, a 19-year-old American law student living in London. Nasr died in September 2025 following a heart rhythm complication. A post-mortem examination suggested that while she had an undiagnosed heart condition, a drop in blood sugar caused by the weight-loss drug may have triggered the event.
Health experts are highlighting constipation as a significant, though often overlooked, risk associated with these drugs. Tirzepatide and similar medications work by slowing down the digestive system, which can lead to severe constipation. This condition, affecting a substantial portion of the adult population, can be exacerbated by the drugs, potentially leading to a backup in the bowels. Increased pressure on the intestinal lining could, in rare and severe cases, result in a rupture and the leakage of fecal matter into the abdomen.
To mitigate the risk of constipation and other side effects, medical professionals are advising patients to adjust their diets to include more fiber-rich foods such as kiwis, prunes, nuts, seeds, and legumes. Adequate hydration, with a recommended minimum of six to eight glasses of water daily, is also crucial. Regular exercise, including walking, running, and swimming, is also suggested to aid bowel regularity.
Furthermore, experts caution against rapidly increasing drug dosages. Patients typically start on a low dose that is gradually increased. Rushing this titration process, they suggest, may intensify side effects like constipation. Some individuals may also find that maintaining an initial lower dose is sufficient for their weight-loss goals.
Separately, concerns have been raised about NHS cost-cutting measures that may be leading to the removal of elderly and vulnerable patients from GP surgery lists if they have not attended appointments for some time. This practice, intended to reduce administrative costs, could inadvertently prevent those most in need from accessing healthcare services.